Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Malignant Melanoma

Free Subscription 04.06.2008 2 Ann Surg Oncol 4 Anticancer Res 1 Biochem Biophys Res Commun 1 Br J Cancer 1 Int J Cancer 1 J Clin Oncol 1 J Invest Dermatol 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. KROON HM , Moncrieff M, Kam PC, Thompson JF, et al
   Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience.
   Ann Surg Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   
2. NOWECKI ZI , Rutkowski P, Michej W
   The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2-pT3).
   Ann Surg Oncol. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Anticancer Res

3. FERNANDES N , Jung M, Daoud A, Mo H, et al
   Biphenylalkylacetylhydroquinone ethers suppress the proliferation of murine B16 melanoma cells.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
4. NUZZO C , Zeuli M, Ferraresi V, Ciccarese M, et al
   Unexpected clinical outcome in a patient with liver and brain metastasis from melanoma.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
5. NIEDER C , Adam M, Astner ST
   Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   
6. CHARACIEJUS D , Pasukoniene V, Jonusauskaite R, Azlauskaite N, et al
   Peripheral blood CD8highCD57+ lymphocyte levels may predict outcome in melanoma patients treated with adjuvant interferon-alpha.
   Anticancer Res. 2008;28.
   PubMed     Related articles    Abstract available
   
   

   
   Biochem Biophys Res Commun

7. KANG S , Yang C, Luo R
   Induction of CCL2 by siMAML1 through upregulation of TweakR in melanoma cells.
   Biochem Biophys Res Commun. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Br J Cancer

8. GUGGENHEIM M , Dummer R, Jung FJ, Mihic-Probst D, et al
   The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma - a retrospective analysis of 392 cases.
   Br J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   Int J Cancer

9. DOWNING A , Yu XQ, Newton-Bishop J, Forman D, et al
   Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
   Int J Cancer. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   J Clin Oncol

10. CHAPMAN PB
    Combining a peptide vaccine with high-dose interleukin-2.
    J Clin Oncol. 2008;26:2250-1.
    PubMed     Related articles   
    
    

    
    J Invest Dermatol

11. JOVANOVIC B , Krockel D, Linden D, Nilsson B, et al
    Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous Melanoma.
    J Invest Dermatol. 2008;.
    PubMed     Related articles    Abstract available
    
    

    
    Oncogene

12. BANERJEE T , Duhadaway JB, Gaspari P, Sutanto-Ward E, et al
    A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase.
    Oncogene. 2008;27:2851-7.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: